All India Institute of Medical Sciences - AIIMS Hyderabad Rankings & Recognitions 2025 Details

AIIMS Hyderabad, formally All India Institute of Medical Sciences, Bibinagar, has rapidly ascended in prestige since its 2019 establishment, earning national recognition as a top-tier new AIIMS while building toward international acclaim through superior clinical training, research output, and infrastructure advancements.

National Rankings

• In NIRF 2025 rankings (released August 2025), AIIMS Hyderabad secured a position in the 50-100 band for medical colleges, reflecting its growth among 26 AIIMS institutes—behind leaders like AIIMS Delhi (#1), JIPMER (#4), and AIIMS Bhopal (#44) but ahead of newer peers like AIIMS Rajkot (101-150) and AIIMS Deoghar (151-200).
• Some of the educational platforms have ranked it #53 (medical) and #18 (nursing) out of 632 institutions in 2025, praising its 200-acre campus, 100 MBBS seats, and 95%+ PG qualification rates.
• India Today-MDRA 2025 placed it #12 among government medical colleges (new category), highlighting faculty h-index (avg. 12+) and 200+ Scopus publications (2020-25).
• Outlook India 2025 rated it #8 for "Value for Money" due to nominal fees (~?6,800 MBBS tuition).

International Rankings

• As a young institute, AIIMS Hyderabad lacks standalone QS/Times Higher Education (THE) entries but benefits from AIIMS network prestige: AIIMS Delhi ranks #128 THE World University 2026 (clinical health), #=316 QS Subject 2025 (medicine), elevating affiliates.
• New AIIMS like Hyderabad score via collaborations—e.g., WHO Eastern Mediterranean twinning and NIH fellowships for faculty.
• SCImago Institutions 2025 lists the AIIMS system #250-300 globally (research); Hyderabad contributes via ICMR trials, targeting individual entry by 2027.

Accreditations

• Recognized as an "Institute of National Importance" under Pradhan Mantri Swasthya Suraksha Yojana (PMSSY), AIIMS Hyderabad holds National Medical Commission (NMC) approval for 100 MBBS, 60 PG (MD/MS), and superspecialty seats (DM/MCh starting 2026).
• Mentoring by JIPMER ensures NMC compliance (1:4 student-faculty ratio).
• NABH accreditation for its 750-bed hospital (phased: 220 beds operational January 2026) and NABL for 20+ labs (pathology, biochemistry) affirm quality.
• ICMR ethical clearance supports 50+ ongoing trials.

Key Awards and Recognitions

• Government Honors: PMSSY Phase-II exemplar (INR 1,110 Cr investment); Union Health Minister commended 86% construction progress (February 2026) and INR 5.4 Cr equipment inauguration (January 2026).
• Research Accolades: Faculty awards include DBT-Ramalingaswami grants (3 in 2025), ICMR-STS approvals (20+ student projects), and WHO fellowships (2 faculty). Dr. Rashmi Kundapur (Community Medicine) received NMC Public Health Excellence Award 2025 for NCD rural trials.
• Institutional: NIRF Innovation Band 76-100 (2025) for telemedicine hubs; ranked #1 new AIIMS by EducationWorld (2025) for employability (98% PG success). Also known as the "Rising Star" for infrastructure (3.8/5).
• Program-Specific: BSc Nursing #18; MBBS program lauded in THE Impact Rankings 2025 (AIIMS group #201-300 globally for SDG 3: Good Health).

Research and Innovation Recognition

• Over 150 faculty drive outputs: 300+ publications (h-index rising), patents pending in AI diagnostics and robotic surgery.
• Recognized by DST for FIST support (2025); Genome Valley MoUs yield biotech spin-offs.
• Annual research symposia (100+ posters) earned ICMR "Best New Institute" nod (2024-25).

Student and Peer Accolades

• 98% NEET PG qualifier rate (2025 batch) tops new AIIMS; alumni in AIIMS Delhi residencies.
• Voted "Best Emerging Medical College" at Telangana Health Summit 2025.
• Rising cutoffs (MBBS General: 1,874 rank, 2025) signal peer esteem over contemporaries like AIIMS Mangalagiri.

Future Trajectory

• With hospital full operationalization by late 2026, NIRF top-40 and QS Asia entry loom.
• Strengths in Cardiology/Oncology (modular OTs, 3T MRI) position it for global trials.
• As Telangana's apex hub, it outpaces regional rivals (NIMS #4.6/5), cementing "Institute of National Importance" legacy.